You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 8, August 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  FROM THE MMWR
 This Article
 •Excerpt
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Persistent Lack of Detectable HIV-1 Antibody in a Person With HIV Infection—Utah, 1995

Arch Dermatol. 1996;132(8):873-874.


References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.


1. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994; 344:1333-4. PUBMED
2. Pau CP, Hu DJ, Spurill C, et al. Surveillance for HIV-1 group O infections in the United States. Transfusion 1996 (in press).
3. Farzadegan H, Polis MA, Wolinsky SM, et al. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study. Ann Intern Med 1988;108:785-90. FREE FULL TEXT
4. Roy MJ, Damato JJ, Burke DS. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 1993;269:2786-9.
5. Martin-Rico P, Pedersen C, Skinhoj P, Nielsen C, Lindhardt B. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man. AIDS 1995;9:95-6. PUBMED
6. Soriano V, Dronda F, Gonzalex-Lopez A, Chaves F, Bravo R, Gutierrez M. HIV-1 causing AIDS and death in a seronegative individual. Vox Sang 1994; 67:410-1. PUBMED
7. Food and Drug Administration. Revised recommendations for the prevention of human immunodeficiency virus transmission blood and blood products. Memorandum to all registered blood and plasma establishments. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1992.
8. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5. FREE FULL TEXT
9. Food and Drug Administration. Recommendations for donor screening with a licensed test for HIV-1 antigen. Memorandum to all registered blood and plasma establishments. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Biologics Evaluation and Research, 1995.
10. CDC. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. MMWR 1996;45(no. RR-2).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.